BioPlus Acquisition Corp.

NASDAQ: BIOS · Real-Time Price · USD
10.79
-0.01 (-0.09%)
At close: Oct 06, 2023, 9:46 PM

BioPlus Acquisition Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
1.24M 2.32M 1.57M 659.13K 24.92K -261.82K -145.93 -0.88 -1.14 -5
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Non-Cash Items
-2.52M -2.6M -1.89M -949.5K -280.35K -45.37K -688.13 -9.24 1.03 5.00
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
400.07K -40.33K 87.72K 102.75K 148.57K 140.7K n/a n/a n/a n/a
Operating Cash Flow
-878.92K -315.61K -230.5K -187.62K -106.86K -166.49K -834.06 -10.12 -0.11 n/a
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
104.46K n/a n/a n/a n/a n/a -255.93K n/a n/a n/a
Investing Cash Flow
104.46K n/a n/a n/a n/a n/a -255.93K n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-104.71K n/a n/a n/a -67.5 n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-103.61K 210.68K 263.73K 7.33K -41.17K -26.33K 257.45K -12.63 -1.2 25.00
Financial Cash Flow
-103.61M 210.68K 263.73K 7.33K -41.17K -26.33K 257.45K -12.63 -1.2 25.00
Net Cash Flow
-32.92K -104.93K 33.23K -187.62K -148.03K -192.82K 691.94 -22.75 -1.31 25.00
Free Cash Flow
-878.92K -315.61K -230.5K -187.62K -106.86K -166.49K -834.06 -10.12 -0.11 n/a